Navigation Links
Jean-Pierre Lehner Appointed Chief Medical Officer
Date:2/11/2009

PARIS, Feb. 11 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that Jean-Pierre Lehner, M.D., is appointed Senior Vice-President, Chief Medical Officer (CMO). He was previously Senior Vice President, Medical & Regulatory Affairs.

Jean-Pierre Lehner reports to Marc Cluzel, Senior Vice President, Research & Development, who declared: "The newly created role of Chief Medical Officer is a further demonstration internally and externally of the company's commitment to patient well being".

Patient safety is of the utmost importance to sanofi-aventis. Given the new tools available to enhance pharmacovigilance and monitor the safety of products in development as well as those on the market, this position combines all of the functions related to patient safety to enhance the clarity of purpose and accountability within the company. Pharmacovigilance and Regulatory Affairs will report to the CMO.

The CMO will also chair the internal Benefit/Risk Assessment Committee created in 2008 and which has direct accountability for its conclusions to the CEO.

Jean-Pierre Lehner holds a Medical degree from the School of Medicine University of Paris, France. After spending four years as Chef de Clinique, assistant of Paris Hospitals, Department of Cardiology (Pr Tricot), Hopital Bichat, Paris, France, Jean-Pierre Lehner joins Roussel Laboratories in 1981 as Medical Director (1981-1986), then he is named Medical Director of Roussel-Uclaf (1986-1992). He is successively Senior Director of Clinical Investigations of Sanofi Recherche (1992-1996), Scientific Senior Director of Sanofi Winthrop (1996-2002), Vice President Medical Affairs Europe of sanofi-aventis (2003-2005). As from 2005, Jean-Pierre Lehner was Senior Vice-President, Medical & Regulatory Affairs sanofi-aventis.

About sanofi-aventis

Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).

    CONTACT:  Jean-Marc Podvin
              Vice President, Media Relations
              sanofi-aventis
              +331-53-77-4223


'/>"/>
SOURCE sanofi-aventis
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Alice Stollenwerk Petrulis, MD, FACP, Appointed to NQF Care Coordination Committee
2. Former Assistant Secretary for Aging, The Honorable Josefina G. Carbonell, Appointed Senior Vice President at Independent Living Systems
3. Perrigo Company Appointed Generic Distributor by Medimetriks Pharmaceuticals
4. Asthma & Allergy Foundation CEO Appointed to NIH Council
5. Ad de Waard Appointed Vice President of International Sales and Marketing at Accumetrics, Inc.
6. Latino Psychologist Appointed to Mental Health Post in Commonwealth
7. Dr. Jane L. Delgado Appointed By Senate Majority Leader to Board of National Urban Air Toxics Research Center
8. Universal Health Realty Income Trust Announces Marc D. Miller Appointed to Board of Trustees and Dividend Increase
9. Craig A. Norris Appointed to Providence Service Corporation Board of Directors
10. Jonathan Jacobson Appointed General Manager, Global Business Strategies & Operations, Menicon Co., Ltd.
11. Mobile Imaging Innovator, Mobile Diagnostic Centers LP, Appoints New CEO : Mobile Imaging Development's Limited Partnership, Mobile Diagnostic Centers LP. Has Appointed Patrick McNamara as CEO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... FL (PRWEB) , ... February 10, 2016 , ... AxoGen, ... market, will report results for the fourth quarter and full year ended December 31, ... host a conference call and webcast for the investment community following the release at ...
(Date:2/10/2016)... ... February 10, 2016 , ... AHRA: The ... and inspirational speaker Jan Fox will serve as keynote speaker at the organization’s ... participants with tools to more effectively communicate with their own organizational staff and ...
(Date:2/10/2016)... ... February 10, 2016 , ... For additional information contact Phyllis Strupp ... book "Better with Age: The Ultimate Guide to Brain Training" by award-winning author ... The book’s publication date is March 16, 2016. A free review copy is ...
(Date:2/10/2016)... Beach, Florida (PRWEB) , ... February 10, 2016 ... ... Country Club) announced that it has been awarded the prestigious Distinguished Emerald Club ... World award program conducted by BoardRoom magazine, one of the most respected trade ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... biocompatible columns and accessories. These PEEK-lined stainless steel (PLS) columns combine the strength ... solution that ensures the integrity of biological samples while operating at ultra-high pressures ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... -- Urologix, the market leader for in-office minimally invasive ... (BPH), announces new private ownership and is operating as ... industry veteran of more than 20 years, has been ... Plymouth, Minn. The company,s two ... RF Therapy, will continue to be broadly available and ...
(Date:2/10/2016)... Feb. 10, 2016  Rich Pharmaceuticals, Inc. (OTC Markets: ... 1-for-100 reverse split of its issued and outstanding shares ... on Thursday, February 11, 2016. The Company,s common stock ... number 76303T308 and temporary ticker symbol "RCHAD". After 20 ... the ticker symbol (RCHA).  --> ...
(Date:2/10/2016)... 10, 2016  Oxis International Inc. (OTC/QB: OXIS) announced ... described as a "clinical trial triumph" after one of ... complete cancer remission. Daniel Vallera , ... Cancer Center. --> Daniel Vallera , ... Cancer Center. --> An article on ...
Breaking Medicine Technology: